Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 470-476 , April 2010

Preimplantation genetic haplotyping: 127 diagnostic cycles demonstrating a robust, efficient alternative to direct mutation testing on single cells

Received 27 February 2009 ,Revised 27 March 2009 ,Accepted 16 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Pamela Renwick is a consultant clinical scientist and is head of the molecular genetic group within the Centre for Preimplantation Genetic Diagnosis at Guy’s and St. Thomas’ Hospital; this service provides preimplantation genetic diagnosis (PGD) for couples at risk of inherited single-gene defects. She introduced the approach of preimplantation genetic haplotyping in 2006 which won the centre a national Hospital Doctor award for innovation. She has recently joined the steering committee of the ESHRE PGD consortium.

PII: S1472-6483(10)00007-6

doi: 10.1016/j.rbmo.2010.01.006

Reproductive BioMedicine Online
Volume 20, Issue 4 , Pages 470-476 , April 2010